Report cover image

Global Automated Nucleic Acid Extraction Devices Market Growth 2025-2031

Published Nov 11, 2025
Length 137 Pages
SKU # LPI20547420

Description

The global Automated Nucleic Acid Extraction Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Automated devices significantly reduce the time and labour required to manually extract nucleic acids from the same number of samples. They also avoid the introduction of human error that can occur during manual extraction. The automated nucleic acid extraction devices are adaptable and efficient systems for fully automated nucleic acid isolation.

United States market for Automated Nucleic Acid Extraction Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Automated Nucleic Acid Extraction Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Automated Nucleic Acid Extraction Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Automated Nucleic Acid Extraction Devices players cover QIAGEN, F. Hoffmann-La Roche Ltd, Analytik Jena GmbH+Co. KG, Thermo Fisher Scientific Inc, AccuBioMed Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Automated Nucleic Acid Extraction Devices Industry Forecast” looks at past sales and reviews total world Automated Nucleic Acid Extraction Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Automated Nucleic Acid Extraction Devices sales for 2025 through 2031. With Automated Nucleic Acid Extraction Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated Nucleic Acid Extraction Devices industry.

This Insight Report provides a comprehensive analysis of the global Automated Nucleic Acid Extraction Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automated Nucleic Acid Extraction Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automated Nucleic Acid Extraction Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated Nucleic Acid Extraction Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated Nucleic Acid Extraction Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Automated Nucleic Acid Extraction Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Instruments
Kits

Segmentation by Application:
Hospitals
CDC
Health Bureau
Maternal and Child Health Hospital
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
QIAGEN
F. Hoffmann-La Roche Ltd
Analytik Jena GmbH+Co. KG
Thermo Fisher Scientific Inc
AccuBioMed Co., Ltd
AUTOGEN INC
Bioneer Corporation
Illumina, Inc.
Tecan Trading AG
Merck KGaA
BD
PerkinElmer, Inc
DiaSorin SpA
TianLong Science and Technology Co., Ltd
Jiangsu Bioperfectus Technologies Co., Ltd
Zybio Inc
Hangzhou Bioer Technology
Daan Gene Co., Ltd
Sansure Biotech
BioTeke Corporation(wuxi) Co.,Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated Nucleic Acid Extraction Devices market?

What factors are driving Automated Nucleic Acid Extraction Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated Nucleic Acid Extraction Devices market opportunities vary by end market size?

How does Automated Nucleic Acid Extraction Devices break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

137 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Automated Nucleic Acid Extraction Devices by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Automated Nucleic Acid Extraction Devices by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.